CoChat
Sign Up
Cited by 258Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorParanormal Experiences and Beliefs

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin

Open access
Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., Hutten, N. R. P. W., Jansen, J. F. A., Stiers, P., Feilding, A., Ramaekers, J. G.·2020·Neuropsychopharmacology
DOI 10.1038/s41386-020-0718-8PMC PMC7547711
Open this paper in CoChat — free accountOpen PDF

Abstract

There is growing interest in the therapeutic utility of psychedelic substances, like psilocybin, for disorders characterized by distortions of the self-experience, like depression. Accumulating preclinical evidence emphasizes the role of the glutamate system in the acute action of the drug on brain and behavior; however this has never been tested in humans. Following a double-blind, placebo-controlled, parallel group design, we utilized an ultra-high field multimodal brain imaging approach and demonstrated that psilocybin (0.17 mg/kg) induced region-dependent alterations in glutamate, which predicted distortions in the subjective experience of one’s self (ego dissolution). Whereas higher levels of medial prefrontal cortical glutamate were associated with negatively experienced ego dissolution, lower levels in hippocampal glutamate were associated with positively experienced ego dissolution. Such findings provide further insights into the underlying neurobiological mechanisms of the psychedelic, as well as the baseline, state. Importantly, they may also provide a neurochemical basis for therapeutic effects as witnessed in ongoing clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41386-020-0718-8

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Retrospective ratings of drug effects. Violin plots displaying reported scores on the 5 main dimensions of the 5D-ASC (a), ratings on the ego dissolution inventory (b) for each treatment group. Each stick in the violin indicates a data point, whereas the density is scaled to the relative count across all bins.
Fig. 1 Retrospective ratings of drug effects. Violin plots displaying reported scores on the 5 main dimensions of the 5D-ASC (a), ratings on the ego dissolution inventory (b) for each treatment group. Each stick in the violin indicates a data point, whereas the density is scaled to the relative count across all bins.CC BY · PubMed Central
Fig. 2 Raincloud plots displaying metabolite concentrations in the mPFC and the hippocampus, which demonstrated significant differences between treatment groups. a glutamate in the mPFC, b NAA in the mPFC, c glutamate in the hippocampus, d GABA in the mPFC. The plot consists of a probability density plot, a boxplot, and raw data points. In the boxplot, the line dividing the box represents the median of the data, the ends represent the upper/lower quartiles, and the extreme lines represent the highest and lowest values excluding outliers. The code for raincloud plot visualization has been adapted from Allen et al. [99].
Fig. 2 Raincloud plots displaying metabolite concentrations in the mPFC and the hippocampus, which demonstrated significant differences between treatment groups. a glutamate in the mPFC, b NAA in the mPFC, c glutamate in the hippocampus, d GABA in the mPFC. The plot consists of a probability density plot, a boxplot, and raw data points. In the boxplot, the line dividing the box represents the median of the data, the ends represent the upper/lower quartiles, and the extreme lines represent the highest and lowest values excluding outliers. The code for raincloud plot visualization has been adapted from Allen et al. [99].CC BY · PubMed Central
Fig. 3 Within-network resting state functional connectivity. Resting state networks that demonstrated significant differences in within-network functional connectivity, for each group (placebo and psilocybin).
Fig. 3 Within-network resting state functional connectivity. Resting state networks that demonstrated significant differences in within-network functional connectivity, for each group (placebo and psilocybin).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 102 references

Cited by

Sorted by citations

See all 258

Related

Metadata

Authors
Mason, N. L., Kuypers, K. P. C., Müller, F., Reckweg, J., Tse, D. H. Y., Toennes, S. W., Hutten, N. R. P. W., Jansen, J. F. A., Stiers, P., Feilding, A., & Ramaekers, J. G.
Affiliations
  • Maastricht University (NL)
  • University of Basel (CH)
  • Goethe University Frankfurt (DE)
  • Maastricht University Medical Centre (NL)
  • Beckley Foundation (GB)
Corresponding author
  • Mason, N. L.
  • Ramaekers, J. G.
ORCID
Venue
Neuropsychopharmacology
Publisher
Springer Science and Business Media LLC
Published
2020-05-23
Volume
45
Issue
12
Pages
2003-2011
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
DOI
10.1038/s41386-020-0718-8
PMC
PMC7547711
OpenAlex
W3027590463
Cited by
258
References
102
Citations by year
2026: 36 · 2025: 41 · 2024: 40 · 2023: 62 · 2022: 42 · 2021: 32 · 2020: 5
FWCI
14.08
Type
journal article
Language
en
Open access
Licence
Locations
  • Neuropsychopharmacology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion, cc-by)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
Beckley Foundation
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
Keywords
psilocybin, glutamate, ego dissolution, self-experience, medial prefrontal cortex, hippocampus, subjective experience, psychedelics, depression, ultra-high field MRI
MeSH terms
Ego, Hallucinogens, Humans, Psilocybin, Solubility, Glutamic Acid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review